Australia is closely awaiting the arrival of retatrutide, a groundbreaking dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, https://monicatvuo086565.wikitelevisions.com/10040522/retatrutide_australia_a_potential_breakthrough_for_weight_management